The Comprehensive Cell Therapy CDMO, From R&D To cGMP Manufacturing

Theragent’s foundation is rooted in a physician’s dedication to patients, a tireless mission to discover therapies, and a will to break convention to achieve better results. Dr. Yun Yen, an American scientist, physician, and philanthropist, founded a patient-driven CDMO that provides comprehensive yet personalized services throughout all phases of development for cell- and tissue-based advanced therapies.

Theragent is a leading Contract Development and Manufacturing Organization (CDMO) that specializes in personalized cell and tissue-based therapies. With a focus on meeting the needs of patients, Theragent offers comprehensive services from research and development to manufacturing. Our team of highly skilled individuals, including many PhD holders, is dedicated to delivering high-quality therapeutic solutions.

Located in Southern California, Theragent's state-of-the-art facilities are strategically positioned near top biotech companies, cancer centers, and clinical trial sites. Our innovative manufacturing facility, Arcadia cGMP, is designed for flexibility and operational excellence in scaling cell and tissue-based therapeutics.

Theragent provides a wide range of services to advanced therapy developers, including support in raw material qualification, cold chain management, QC testing, and regulatory compliance. We can fill any gaps in the development process to ensure the product reaches the patient on time. With in-house analytics and supply chain management, Theragent offers globally compliant services from Phase 1 to commercial capacity.

Discover how we can provide value-added solutions for your challenging pre-clinical and clinical trial projects.